News | News By Subject | News by Disease News By Date | Search News

Post-Approval (World) News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Roche (RHHBY), Merck & Co. (MRK) Extend Immunotherapy Battle To Breast Cancer     10/17/2014
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children     9/16/2014
Novartis AG (NVS): Rate Of Brain Shrinkage Faster In Multiple Schlerosis Patients     9/10/2014
Amgen (AMGN), Servier Heart Drug Runs Into Safety Concerns In Major Clinical Study     9/4/2014
Sanofi Pasteur (SASY.PA) Touts Positive Trial Data For Fluzone High-Dose Vaccine     8/14/2014
Scientists Retract Narcolepsy Study Linked To GlaxoSmithKline (GSK) Flu Vaccine     8/11/2014
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding     7/25/2014
Shire Reports Results From Two Head-To-Head Studies Comparing Vyvanse® With Concerta® In ADHD Study     7/18/2014
Merck & Co., Inc. (MRK)'s Gardasil HPV Vaccine Doesn't Increase Blood Clot Risk     7/9/2014
Roche (RHHBY) Finds "Serious Flaws" In Recent Study Doubting Tamiflu's Effectiveness     7/1/2014
A 4-Week Hepatitis C Cure? Bristol-Myers Squibb Company (BMY) To Test Drugs With Gilead Sciences, Inc. (GILD)'s Sovaldi     6/23/2014
Pfizer Inc. (PFE) To Showcase Over 10 Abstracts For XELJANZ® At Major Conference     6/11/2014
GlaxoSmithKline (GSK) Touts Positive Incruse™-Ellipta®-Advair®-Diskus® Combo Data     5/20/2014
Head-To-Head Study Reveals Novartis AG (NVS) Lung Drug Not Inferior To GlaxoSmithKline (GSK)'s Seretide     4/28/2014
Saga Continues: Roche (RHHBY)'s Tamiflu No Better Than Tylenol At "Fighting Flu"     4/14/2014

Featured Stories
Ibuprofen No Good in Treating Colds or Sore Throats, University of Southampton Study     11/5/2013
Ticagrelor Does Not Affect Pulmonary Function in ACS Patients, University of Sheffield Study     10/14/2011
Old Osteoporosis Drug May Help In Killing Flu Viruses, University of Hong Kong Study     6/29/2011
One in Five Heart Attack Deaths Could be Prevented with New Drug, University of Sheffield Study     6/14/2011
Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study     5/20/2011
Renal Cancer Drug Temsirolimus Shows Promise Against Mesothelioma, Medical University of Vienna Study     5/2/2011
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study     4/6/2011
Infectious Diseases Society of America: Linezolid Wins Battle on MRSA Pneumonia, Pitie-Salpetriere Hospital Study     10/27/2010
Boehringer Ingelheim Corporation, Pfizer Inc. (PFE)'s Spiriva Improves Asthma Treatment, Study Shows     9/22/2010
Common Pain Relievers Raise Heart Risk for Healthy Folks, Gentofte University Hospital Study     6/9/2010
Common Cholesterol Drugs, Statins, Fight Cataracts, Too, Tel Aviv University Study     2/12/2010
Switching Immunosuppressants Reduces Cancer Risk In Kidney, Queen Elizabeth Hospital Study     11/2/2009
Combination Antiretroviral Therapy Effective At Reducing HIV Resistance In Mothers And Babies Following Mother-to-child Transmission, Study Funded by Boehringer Ingelheim Corporation     10/28/2009
Rheumatoid Arthritis Biologics Increase Risk of Common Skin Cancer, University of Manchester Study     10/19/2009
Bowel Disease Drugs Increase Cancer Risk, Saint-Antoine Hospital Study     10/19/2009
Celgene International Sárl (CELG) Release: New Analyses Of Oral OTEZLA® (Apremilast) Presented At EADV Show Efficacy In Difficult-To-Treat Areas Of Moderate To Severe Plaque Psoriasis     10/10/2014
Celgene International Sárl (CELG) Release: Oral OTEZLA® (Apremilast) Data Presented At EADV Show Improved Measures Of Health-Related Quality Of Life And Work Productivity In Patients With Moderate To Severe Plaque Psoriasis     10/10/2014
Celgene International Sárl (CELG) To Present Long-Term Efficacy And Safety Data On Oral OTEZLA® (Apremilast) In Plaque Psoriasis And Psoriatic Arthritis At European Academy Of Dermatology And Venereology Congress     10/7/2014
Daiichi Sankyo, Inc. (4568.t) Receives Approval For Additional Indications Of LIXIANA® (Edoxaban) In Japan     9/26/2014
Regeneron Pharmaceuticals, Inc. (REGN) Announces EYLEA® (aflibercept) Injection Approved For The Treatment Of Patients With Myopic Choroidal Neovascularization (CNV) In Japan     9/22/2014
Janssen-Cilag International NV (JNJ) Release: Results From Head-To-Head Studies Of INVOKANA® (Canagliflozin) Versus JANUVIA (Sitagliptin) Highlight The Importance Of Weight-Change On Quality Of Life And Cost Effectiveness Of Canagliflozin Among People With Type 2 Diabetes     9/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Presents New Data Which Demonstrate Reduction Of Injection-Related Adverse Events With The Less Frequent Dosing Of Three-Times-A-Week COPAXONE® (Glatiramer Acetate Injection) 40 Mg Compared To Daily COPAXONE® 20 Mg     9/11/2014
Novaliq GmbH Announces Positive Results From Novatears® Observational Study In Mild To Moderate Evaporative Dry Eye Disease     9/10/2014
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure     9/2/2014
Boehringer Ingelheim Corporation Release: European Society of Cardiology Congress 2014 Hot Line Session: Favourable Effect Of Pradaxa® On Kidney Function Over Time Compared To Warfarin     9/2/2014
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands     7/21/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®)     6/30/2014
H. Lundbeck A/S (LUN.CO) Release: New Study Results Demonstrate Brintellix® (Vortioxetine) Is Efficacious In Asian Patients Suffering From Depression     6/26/2014
Zealand Pharma  (ZEAL.CO) Provides Summary Of New Clinical Data And Information On Lyxumia® (Lixisenatide) And Lixilan Presented At The American Diabetes Association’s 74th Scientific Sessions     6/17/2014
H. Lundbeck A/S (LUN.CO) Release: Brintellix® Demonstrated A Statistically Significantly Superior Improvement Compared To Escitalopram In Improving Sexual Functioning In Well Treated Patients Suffering From Depression And Experiencing Treatment-Emergent Sexual Dysfunction     6/17/2014

More News
No News Posted on that date

Career Tips
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/27/2014
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014
5 Bad Interview Answers To Avoid     10/23/2014
What Separates Good Resumes From Bad Resumes?     10/23/2014
6 Out-Of-The-Box Job Search Ideas That Worked     10/23/2014
Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond     10/17/2014
Biotech’s Biggest Hirers Of The Last 5 Years     10/13/2014
Get A Biotech Job By Thinking Like A Hiring Manager     10/9/2014
7 Deadly Interview Sins     10/9/2014
3 Ways To Uncover A Hidden Job     10/9/2014
3 Crucial Areas To Ask About During The Interview     10/9/2014
How To Land The Perfect R&D Job: A Q&A With Luminex Corporation (LMNX)     9/26/2014
The One Job Search Technique That Eliminates Your Competition     9/25/2014
The Secret To Being The Only Person Applying For the Job     9/25/2014
5 Golden Rules For Negotiating Salary     9/25/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->